DrugDev.org, a global interactive network of clinical trial doctors –presented its Insiders’ Site ID and Study StartUp Report at DIA 2012. Key results from the survey of over 220 project managers from large pharma, small pharma/biotech and CROs were:
56% of clinical trial sites do NOT deliver the expected number of patients
It takes Pharma an average of 6.46 weeks to identify sites, compared to 2 days with best in class offerings,
despite this only 32% are unsatisfied with waiting this long
61% of respondents agreed that there were major challenges with finding good investigators in particular
regions however there was no consensus on where those regions were 84% of respondents from Pharma felt that early engagement with potential investigators would increase recruitment
rates and yet none were looking into early engagement
Candice Yarde, VP of Business Development, DrugDev.org said,“The results of the survey ran the full gamut
from mundane and predictable through to surprising and even shocking. The
relatively high level of satisfaction with existing processes, despite lagging timelines and high rates of site underperformance, highlights a worrying disconnect between senior R&D
leadership,which is demanding transformational improvement and project teams that
have come to accept historical performance as standard.”
Earlier this year, DIA provided companies the opportunity to submit an application detailing how they
embodied the characteristics of “collaboration” and “innovation” and how they fostered th
ose characteristics in their offerings. A DIA panel reviewed the applications and selected five winning entrepreneurs,
including DrugDev.org to showcase their work in the Entrepreneur Pavilion in Booth 1709.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.